Related Experiment Video
Updated: Jul 18, 2025

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
New role of bacteriophages in medical oncology
Mohammad Moradi1, Hadi Esmaeili Gouvarchin Ghaleh2, Masoumeh Bolandian2
1Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Abstract:
Targeted treatment of cancer is one of the most paramount approaches in cancer treatment. Despite significant advances in cancer diagnosis and treatment methods, there are still significant limitations and disadvantages in the field, including high costs, toxicity, and unwanted damage to healthy cells. The phage display technique is an innovative method for designing carriers containing exogenic peptides with cancer diagnostic and therapeutic properties. Bacteriophages possess unique properties making them effective in cancer treatment. These characteristics include the small size enabling them to penetrate vessels; having no pathogenicity to mammals; easy manipulation of their genetic information and surface proteins to introduce vaccines and drugs to cancer tissues; lower cost of large-scale production; and greater stimulation of the immune system. Bacteriophages will certainly play a more effective role in the future of medical oncology; however, studies are in the early stages of conception and require more extensive research. We aimed in this review to provide some related examples and bring insights into the potential of phages as targeted vectors for use in cancer diagnosis and treatment, especially regarding their capability in gene and drug delivery to cancer target cells, determination of tumor markers, and vaccine design to stimulate anticancer immunity.
Insights
Bacteriophages offer a promising, cost-effective approach for targeted cancer therapy and diagnosis. This review explores their potential as vectors for drug delivery, tumor marker detection, and vaccine development in oncology.
Area of Science:
- Oncology
- Biotechnology
- Molecular Biology
Background:
- Targeted cancer treatment faces limitations like high costs, toxicity, and damage to healthy cells.
- Phage display is an innovative technique for developing cancer diagnostic and therapeutic agents.
- Bacteriophages present unique advantages for cancer therapy due to their properties.
Purpose of the Study:
- To review the potential of bacteriophages as targeted vectors in cancer diagnosis and treatment.
- To highlight phage capabilities in drug and gene delivery to cancer cells.
- To explore phage applications in tumor marker determination and anticancer vaccine design.
Main Methods:
- Review of existing literature on bacteriophage applications in oncology.
- Analysis of phage characteristics relevant to cancer targeting and therapy.
- Examination of phage display techniques for peptide design.
Main Results:
- Bacteriophages exhibit properties suitable for cancer treatment, including small size for vessel penetration and non-pathogenicity.
- Phages can be genetically engineered for targeted drug/vaccine delivery and immune stimulation.
- Phage display enables the design of peptides for cancer diagnosis and therapy.
Conclusions:
- Bacteriophages show significant potential as targeted vectors in medical oncology.
- Further research is needed to fully realize the capabilities of phages in cancer diagnosis and treatment.
- Phages offer a promising avenue for developing novel anticancer strategies, including targeted delivery and immunotherapy.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
Microorganisms in Medicine and Therapeutics
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

